Answers are grounded in this paper and cite their sources.
Organ-on-chip technology allowed the identification of specific human microbiome metabolites modulating EHEC pathogenesis. These identified metabolites are sufficient to increase susceptibility to EHEC in our human Colon Chip model and they contribute to species-specific tolerance. This work suggests that higher concentrations of these metabolites could be the reason for higher susceptibility to EHEC infection in certain human populations, such as children. Furthermore, this research lays the foundation for therapeutic-modulation of microbe products in order to prevent and treat human bacterial infection.
No takes yet. Share an insight, caveat, or question.
Tovaglieri et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: